Physician profile
Gilbertas Rimkus
NPI 1326126301
$12,800.31
in general payments reported to CMS, 2019-2025
16 companies · $736 in 2025
The $736 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $673 · 2021: $23.58 · 2022: $24.53 · 2023: $363 · 2024: $160 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527 · Travel and Lodging: $498 · Education: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.97 |
| Travel and Lodging | $497.96 |
| Education | $233.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,145.92 | 2019-2023 | Da Vinci Surgical System |
| Allergan, INC. | $1,512.42 | 2019-2020 | |
| Tela Bio, INC. | $674.05 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $75.69 | 2023-2025 | Phasix Mesh |
| Polynovo North America LLC | $64.82 | 2023-2024 | Novosorb Btm |
| Stryker Corporation | $59.78 | 2023-2025 | Pinpoint, Spy-Phi System, 1788 |
| Ethicon US, LLC | $58.92 | 2020-2025 | Enseal |
| Innocoll Pharmaceuticals Limited | $48.11 | 2021-2022 | |
| Kerecis Limited | $45.30 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Portola Pharmaceuticals, LLC | $31.69 | 2019 | |
| Access Pro Medical, LLC | $18.98 | 2025 | Matriderm |
| Sanara Medtech INC. | $17.38 | 2020 | |
| Boston Scientific Corporation | $14.40 | 2020 | |
| Hydrofera LLC | $14.19 | 2024 | Hydrofera Blue |
| Medtronic, INC. | $13.58 | 2024 | Plasmablade(Tm) |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medela LLC | $5.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbertas Rimkus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.